BENEFITS OF CELLUSCULPT 1. Lying Down for 30 Minutes=5.5 Hours of Exercise 2. Non-invasive treatment with no discomfort,Painless 3. 19% Reduction in Fat 4. 16% Increase in Muscle Mass 5. No downtime 6. Improve confidence in appearance 7. Noticeable, natural-looking results 8. Simple operation and Short treatment times MOST-ADVANCED CelluSculpt’s is the most advanced and intensive electric muscle stimulator. Focused electromagnetic field passes through all skin and fat in order to effectively stimulate the muscle, providing the most intensive continuous contractions which is ideal for muscle growth, and also inducing apoptosis. Additionally, CelluSculpt is an extremely efficient treatment that takes place over the course of 10-14 days, rather than months, and it also produces a more toned abs and uptight buttocks within two-to-four weeks. IDEAL CANDIDATE Those who have unwanted fat in targeted areas.This treatment is ideal for individuals with a low BMI who may not be eligible for other body contouring procedures. CelluSculpt is very effective in eliminating small pockets of fat on individuals who are physically fit. This technology has the potential to provide beneficial muscle tightening in anyone.
Share:
WHAT IS Sincosculpt NEO NOT CAPABLE OF?
Sincosculpt Neo is not a weight loss program and is not a solution for obesity. However, the new treatment vastly expands the spectrum of body types that qualify for the treatment. Unlike its forerunner that was limited to relatively skinny patients, the new Sincosculpt Neo can treat patients of almost any size, up to a BMI of 35.
WHAT IS THE SCIENCE BEHIND THE NEW TREATMENT?
The most significant upgrade provided by the Sincosculpt NEO is the addition of Radiofrequency (RF.) By combining RF energy with electromagnetic energy, the new treatment provides thermal warming deep within the targeted tissues. This provides a synergistic boost to the muscle-building potential of the treatment. In addition, thermal energy disrupts adipocytes to reduce and eliminate nearby fat cells.
